BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2970472)

  • 1. Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients.
    Serra HM; Mant MJ; Ruether BA; Ledbetter JA; Pilarski LM
    J Clin Immunol; 1988 Jul; 8(4):259-65. PubMed ID: 2970472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.
    Serra HM; Krowka JF; Ledbetter JA; Pilarski LM
    J Immunol; 1988 Mar; 140(5):1435-41. PubMed ID: 2964476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of T cells that express CD45R in the CD4+ helper/inducer lymphocyte subset of neonates.
    Bradley LM; Bradley JS; Ching DL; Shiigi SM
    Clin Immunol Immunopathol; 1989 Jun; 51(3):426-35. PubMed ID: 2524299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Shapira R; Froom P; Kinarty A; Aghai E; Lahat N
    Br J Haematol; 1989 Feb; 71(2):223-5. PubMed ID: 2522313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.
    Raziuddin S; Elawad ME
    Clin Exp Immunol; 1990 Jan; 79(1):67-71. PubMed ID: 1967994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in the CD4 + CD45R+ T lymphocytes in normal individuals and its selective decrease in women with idiopathic thrombocytopenic purpura.
    Mylvaganam R; Ahn YS; Sprinz PG; Garcia RO; Harrington WJ
    Clin Immunol Immunopathol; 1989 Sep; 52(3):473-85. PubMed ID: 2527101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.
    Jensen GS; Mant MJ; Belch AJ; Berenson JR; Ruether BA; Pilarski LM
    Blood; 1991 Aug; 78(3):711-9. PubMed ID: 1830500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased proportion of CD4+CDw29+CD45R-UCHL-1+ lymphocytes in the cerebrospinal fluid of both multiple sclerosis patients and healthy individuals.
    Hedlund G; Sandberg-Wollheim M; Sjögren HO
    Cell Immunol; 1989 Feb; 118(2):406-12. PubMed ID: 2562931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200).
    Pilarski LM; Gillitzer R; Zola H; Shortman K; Scollay R
    Eur J Immunol; 1989 Apr; 19(4):589-97. PubMed ID: 2525097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective loss of a subset of T helper cells in active multiple sclerosis.
    Rose LM; Ginsberg AH; Rothstein TL; Ledbetter JA; Clark EA
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7389-93. PubMed ID: 2932738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial meningitis: T cell activation and immunoregulatory CD4+ T cell subset alteration.
    Raziuddin S; el-Awad ME; Mir NA
    J Allergy Clin Immunol; 1991 Jun; 87(6):1115-20. PubMed ID: 1710632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune activation and T cell subset abnormalities in circulation of patients with recently diagnosed type I diabetes mellitus.
    al-Kassab AS; Raziuddin S
    Clin Exp Immunol; 1990 Aug; 81(2):267-71. PubMed ID: 1696864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.
    Goodyear OC; Pratt G; McLarnon A; Cook M; Piper K; Moss P
    Blood; 2008 Oct; 112(8):3362-72. PubMed ID: 18658027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma.
    Pilarski LM; Andrews EJ; Serra HM; Ruether BA; Mant MJ
    Scand J Immunol; 1989 Feb; 29(2):217-28. PubMed ID: 2784225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus.
    Murphy M; Epstein LB
    Clin Immunol Immunopathol; 1992 Feb; 62(2):245-51. PubMed ID: 1530912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in naive and memory CD4+ T cells in healthy human children.
    Pirruccello SJ; Collins M; Wilson JE; McManus BM
    Clin Immunol Immunopathol; 1989 Aug; 52(2):341-5. PubMed ID: 2472239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased frequencies of the CD29 and CD57 markers and decreased frequency of CD45RA within CD4+ and CD8+ subsets after allogeneic bone marrow transplantation in man.
    Møller J; Dickmeiss E; Ryder LP; Jacobsen N; Svejgaard A
    Scand J Immunol; 1991 May; 33(5):499-504. PubMed ID: 1709516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population.
    De Paoli P; Battistin S; Santini GF
    Clin Immunol Immunopathol; 1988 Sep; 48(3):290-6. PubMed ID: 2456868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.